Latest Quest Diagnostics Stories
MADISON, N.J., May 15, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of
Genomic service detects 30 gene mutations to aid in the diagnosis, prognosis, monitoring and treatment selection for several myeloid neoplasms MADISON, N.J., May 4, 2015 /PRNewswire/
BRCA Share(TM) is a novel public-private initiative designed to enhance the clarity and quality of patient testing MADISON, N.J.
As many as 19% of women received false negatives for cervical cancer when HPV-only tested, finds Quest Diagnostics Health Trends(TM) study published in Cancer Cytopathology of 256,648 women, one of
Company's HIT solutions turn health information into actionable insights to help ACOs, health systems, hospitals and physicians improve health care quality, outcomes and efficiencies MADISON,
MADISON, N.J., April 2, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic
AUSTIN, Texas, March 17, 2015 /PRNewswire/ -- Vermillion, Inc.
Proprietary Neurome(TM) service provides insight into the genetic causes of neurological disorders so parents and health care providers can develop personalized care strategies MADISON,
MADISON, N.J., Feb.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.